US Patent 6902744 Exendin agonist formulations and methods of administration thereof
Patent 6902744 was granted and assigned to Amylin Pharmaceuticals on June, 2005 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 6902744 Exendin agonist formulations and methods of administration thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
